Section of Hematology and Coagulation, Department of Internal Medicine, Institute of Medicine, Sahlgrenska University Hospital, Sahlgrenska Academy,, University of Gothenburg, Bruna Stråket 5, 413 45, Gothenburg, Sweden.
McKillop Health Institute, Australian Catholic University, Melbourne, Australia.
Calcif Tissue Int. 2020 Jun;106(6):591-598. doi: 10.1007/s00223-020-00674-7. Epub 2020 Mar 13.
Increased bone loss has been noted in lymphoma patients; however, the incidence of hip fracture is not known. The aim of our study was to explore the risk for hip fracture in patients with lymphoma compared with the entire Swedish population. The risk of hip fracture was determined in a retrospective population cohort study of adult Swedish lymphoma patients (n = 37,236), diagnosed 1995-2015 and compared with the entire Swedish population during the same period. The incidence of hip fracture in lymphoma patients was higher in women than in men, increased by age, and decreased by calendar year as also demonstrated in the total population. 2.2% of the men and 4.7% of women with lymphoma sustained a hip fracture. For the total group of females, the hazard ratio (HR) was 1.19 (95% CI 1.11-1.28) and for men, the hazard ratio was 1.06 (95% CI 0.97-1.17) compared with the Swedish population. The HR for hip fracture (2016) was 2.80 (95% CI 1.20-6.53), 2.04 (95% CI 1.30-3.20), 1.56 (95% CI 1.21-2.01), 1.08 (95% CI 0.89-1.30), and 1.07 (95% CI 0.92-1.25) in females aged 40, 50, 60, 70, and 80 years, respectively. Corresponding figures for men were not significant in 2016. Unmarried men with lymphoma had a two times higher risk for hip fracture (HR 2.02 95% CI 1.63-2.50) compared with married men. Patients with lymphoma had an increased risk of hip fracture, especially younger women and unmarried men. The incidence of hip fracture is decreased by calendar year in the lymphoma patients and the entire Swedish population.
淋巴瘤患者的骨丢失增加已得到证实;然而,髋部骨折的发生率尚不清楚。我们的研究旨在探讨与整个瑞典人群相比,淋巴瘤患者发生髋部骨折的风险。在一项回顾性的瑞典淋巴瘤成年患者(n=37236)人群队列研究中,我们确定了髋部骨折的风险,这些患者于 1995 年至 2015 年间被诊断为淋巴瘤,并与同期的整个瑞典人群进行了比较。与男性相比,女性淋巴瘤患者髋部骨折的发生率更高,且随年龄增长而增加,随日历年份而减少,这在整个人群中也是如此。2.2%的男性和 4.7%的女性淋巴瘤患者发生了髋部骨折。对于女性总人群,风险比(HR)为 1.19(95%可信区间 1.11-1.28),男性 HR 为 1.06(95%可信区间 0.97-1.17),与瑞典人群相比。2016 年髋部骨折(2016 年)的 HR 为 2.80(95%可信区间 1.20-6.53)、2.04(95%可信区间 1.30-3.20)、1.56(95%可信区间 1.21-2.01)、1.08(95%可信区间 0.89-1.30)和 1.07(95%可信区间 0.92-1.25),分别为 40、50、60、70 和 80 岁的女性。相应的男性数字在 2016 年并不显著。与已婚男性相比,未婚的淋巴瘤男性髋部骨折的风险高两倍(HR 2.02 95%可信区间 1.63-2.50)。淋巴瘤患者髋部骨折的风险增加,尤其是年轻女性和未婚男性。淋巴瘤患者和整个瑞典人群的髋部骨折发生率随日历年份减少。